⏳ Fetching live dividend data...
Home › Calculator › CLNNW Dividend Calculator 2026
Clene Inc. · NASDAQ
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CLNNW → $1.0099854915901283e+42M in 10 years · $84,165,383,659,028,950,000,000,000,000,000,000,000,000,000,000.00/month
Clene Inc. is a clinical-stage pharmaceutical firm dedicated to the discovery, development, and market introduction of innovative therapeutic agents derived from clean-surfaced nanotechnology (CSN). The company's primary drug candidate, CNM-Au8, is currently undergoing extensive clinical evaluation for various neurological conditions. For Amyotrophic Lateral Sclerosis (ALS), it's being tested in a pivotal Phase 2/3 registrational clinical trial, building on a previously completed Phase 2 "proof-of-concept" study in patients with early symptomatic ALS. Further research includes two finished open-label, investigator-blinded Phase 2 trials that explored its effects on brain energy metabolites. CNM-Au8 has also completed a Phase 2 trial focused on addressing visual pathway deficits in chronic optic neuropathy, aiming to promote remyelination in individuals with stable relapsing Multiple Sclerosis. Another Phase 2 trial is also targeting Parkinson's Disease patients. Beyond its flagship candidate, Clene's portfolio features CNM-AgZn17, a gel polymer suspension containing silver and zinc ions, which is under development for treating infectious diseases and supporting wound healing. Additionally, the company offers CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent designed to combat various infections, including conditions like COVID-19, and to bolster immune responses for symptom relief. Clene also markets and distributes dietary supplements, specifically rMetx, a liquid supplement featuring zinc-silver ions, and KHC46, a liquid gold supplement with ultra-low concentrations of gold nanoparticles. The company maintains its headquarters in Salt Lake City, Utah.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CLNNW position with:
Real after-tax yield depends on where you live and how you hold CLNNW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 94444.44% | 94441.64% | $9,444,444 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 88888.89% | 88886.09% | $8,888,889 / yr |
| 🇬🇧 UK ISA | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| 🇬🇧 UK Taxable | 8.75% | 101388.89% | 101386.09% | $10,138,889 / yr |
| 🇨🇦 TFSA | 0% | 111111.11% | 111108.31% | $11,111,111 / yr |
| 🇨🇦 CA Taxable | 25% | 83333.33% | 83330.53% | $8,333,333 / yr |
| 🇦🇺 Super (pension) | 15% | 94444.44% | 94441.64% | $9,444,444 / yr |
| 🇦🇺 AU Taxable | 30% | 77777.78% | 77774.98% | $7,777,778 / yr |
| 🇩🇪 DE Taxable | 26.375% | 81805.55% | 81802.75% | $8,180,555 / yr |
| 🇫🇷 FR Taxable | 30% | 77777.78% | 77774.98% | $7,777,778 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CLNNW pays quarterly — 4 times per year. Next ex-div: TBD.
How CLNNW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CLNNW sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CLNNW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Clene Inc. (CLNNW) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 111111.11% based on an annual payout of $2.00 per share.
Clene Inc. (CLNNW) is a healthcare stock currently trading at $0.00 with a dividend yield of 111111.11%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →